This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (17)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Medical Practice, Other  • Psychiatry  • Attention Deficit Hyperactivity Disorder  • Alert me on articles by topic

Associated Symptoms, Diagnoses, and Health Care Services in a Health Maintenance Organization

Lynn L. DeBar, PhD, MPH; Frances Lynch, PhD, MsPH; James Powell, MD; John Gale, MD

Arch Pediatr Adolesc Med. 2003;157:150-157.

Background  Recent pharmacoepidemiological reports have contributed to concerns about frequent and perhaps indiscriminate psychopharmacotherapy for very young children.

Objective  To examine the diagnoses, symptoms, and health care services associated with preschool children receiving psychotropic medication.

Design  Population-based pharmacoepidemiological analysis of electronic medical records, paper medical and mental health charts, and pharmacy records from 1997 and 1998.

Setting  A large Pacific Northwest health maintenance organization.

Participants  Preschool children receiving psychotropic medication (psychostimulants, antidepressants, neuroleptics, or ₂-adrenergic agonists).

Measures  Physician-reported mental health diagnoses and related symptoms, functional impairment, family and participant characteristics, and the types and level of associated medical and mental health services.

Results  Of 743 preschool children who clinicians identified as having behavioral or emotional problems, 120 (16%) received psychotropic medication; 57 children (48%) were prescribed a stimulant medication only, and 60 (50%) received a diagnosis of attention-deficit/hyperactivity disorder. Most children had substantial psychosocial risk factors, including parents with psychiatric or substance abuse problems (71%; n = 85), documented histories of abuse (29%; n = 35), and out-of-home placement (31%; n = 37). Four of 5 children or families (83%; n = 99) received psychosocial services in addition to pharmacotherapy. On average, children received psychotropic medication at least 6 months after initial identification of a behavioral or mental health problem.

Conclusions  Despite commentary by the popular media about widespread psychopharmacotherapy for very young children, such treatment was only infrequently received in this health plan. Most children receiving psychopharmacotherapy had substantial additional risk factors and were receiving psychosocial services for mental health or behavioral management.

From the Kaiser Permanente Center for Health Research (Drs DeBar and Lynch) and the Northwest Permanente Medical Group (Drs Powell and Gale), Portland, Ore.

RELATED ARTICLE

Use of Psychotropic Medications in Young, Preschool Children: Primum Non Nocere
William J. Barbaresi
Arch Pediatr Adolesc Med. 2003;157(2):121-123.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Recent Trends in Stimulant Medication Use Among U.S. Children
Zuvekas et al.
Am. J. Psychiatry 2006;163:579-585.
ABSTRACT | FULL TEXT  

Trends in the Use of Psychotropic Medications Among Adolescents, 1994 to 2001
Thomas et al.
Psychiatr. Serv. 2006;57:63-69.
ABSTRACT | FULL TEXT  

Attention Deficit-Hyperactivity Disorder
Rappley
NEJM 2005;352:165-173.
FULL TEXT  

Is Use of Psychotropic Agents Appropriate in Preschool Children?
JWatch Pediatrics 2003;2003:7-7.
FULL TEXT  

Use of Psychotropic Medications in Young, Preschool Children: Primum Non Nocere
Barbaresi
Arch Pediatr Adolesc Med 2003;157:121-123.
FULL TEXT